Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

WALGREENS BOOTS ALLIANCE

(WBA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Walgreens Boots Alliance : Releases New Corporate Social Responsibility Report

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/12/2019 | 04:01am EDT

Highlights:

  • Helped to provide life-changing vitamins and minerals to more than 160 million children and women through a CSR partnership with Vitamin Angels
  • Helped to provide more than 34 million lifesaving vaccines to children in the developing world through a CSR partnership with the UN Foundation
  • Announces new and expanded UK CSR partnerships with The Prince’s Trust, WE

Walgreens Boots Alliance (Nasdaq: WBA) today published its 2018 Corporate Social Responsibility (CSR) Report, which showcases the company’s global sustainability initiatives to prevent opioid abuse, support cancer patients and their families and address malnutrition and other health issues in communities around the world.

WBA’s CSR strategy is largely focused on health care initiatives, particularly access and affordability, due to the nature of the company’s pharmacy and wellbeing business. Working with partner organizations the company has helped provide life-changing vitamins and minerals to more than 160 million children and women, and more than 34 million lifesaving vaccines to children in the developing world.

“As a pharmacy-led global company we have a tremendous opportunity to change the world for better. Through our health-centered initiatives we have had a positive impact on millions of people in the communities we serve and in underserved areas across the planet,” said Ornella Barra, Walgreens Boots Alliance co-chief operating officer and chairman of the Corporate Social Responsibility Committee. “We believe that we can drive business results while benefitting society and that is why we have embedded CSR in everything we do.”

The report was launched today at the Boots UK support office in Nottingham, coinciding with the celebration of 170 years since Boots was founded here. Over this time Boots UK has pioneered CSR work in many areas, such as product sustainability, community partnerships and sustainability reporting.

Partnerships have been a core WBA strategy for delivering health benefits for communities, customers and our employees. In keeping with this approach, Boots UK also announced today new and expanded CSR partnerships:

  • A new partnership with The Prince’s Trust aims to increase employment opportunities for young people across the UK, by supporting them to develop skills for the workplace and by providing in-store opportunities.
  • An extension of its partnership with WE – a family of organizations that make doing good, doable - aims to help a generation of young people in Nottingham fulfill their potential. The UK WE Schools program empowers young people to develop their personal wellbeing and workplace readiness through social action. In November 2019, Boots and WE will host the first WE Day Community Nottingham youth celebration event.

WBA achieved a number of sustainability milestones in the 12 months that ended August 31, 2018. Highlights in the company’s 2018 CSR Report include:

Opioid abuse prevention: Walgreens expanded its efforts to combat overdose-related deaths. Between May 2016 and August 2018, Walgreens safe medication disposal kiosk program collected and safely disposed more than 410 tons (372 metric tonnes) of unused and unwanted medication to curb the abuse of prescription drugs.

Dementia awareness: Boots UK continued to work with Dementia Friends – an Alzheimer’s Society initiative to change people’s perceptions and understanding of dementia. Boots has helped to create more than 38,000 Dementia Friends, people with an understanding of what it can be like to live with dementia. There is at least one Dementia Friend in every Boots store in Great Britain, to help people who shop at Boots stores feel safe, calm and comfortable.

Cancer programs: We extended our partnership with the European Organisation for Research and Treatment of Cancer (EORTC) with a commitment to raise €5 million by 2023 to further advance our joint goals of providing better treatment and quality of life for people with cancer, in addition to the more than €5 million raised previously. Also, this year Boots UK is celebrating its 10-year anniversary of working with Macmillan Cancer Support. Boots UK employees and customers have raised more than £16.6 million ($25.1 million) for Macmillan Cancer Support as of August 31, 2018.

Emissions reduction and waste initiatives: WBA has reduced its carbon footprint by 15.3 percent since fiscal 2016, the baseline year for the company’s CSR performance data. In fiscal 2018 Walgreens distribution facilities in the U.S. and Puerto Rico diverted 93 percent of waste from landfills. Walgreens also diverted more than 3.4 million pounds of safe and unused toiletries, food and household items from landfills by donating the items to Feeding America.

Product transparency: WBA has implemented a chemicals management program to assess and restrict the use of certain chemicals and ingredients in products it sells and provide greater transparency for consumers.

The WBA 2018 CSR Report was prepared in accordance with the GRI Standards: Core option. The GRI Standards are the world’s most widely used set of sustainability reporting standards. The full report is available at www.walgreensbootsalliance.com. To learn more about WBA and sustainability, connect with the company on WBA Linkedin.

Cautionary Note Regarding Forward-Looking Statements: All statements in this release and related CSR report that are not historical, including goals for and projections of future results, the expected execution and effect of our Corporate Social Responsibility strategies and initiatives and the amounts and timing of their expected impact, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, known or unknown, including those described in Item 1A (Risk Factors) of Walgreens Boots Alliance’s Form 10-K for the fiscal year ending August 31, 2018, which is incorporated herein by reference, and in other documents that Walgreens Boots Alliance files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially. These forward-looking statements speak only as of the date they are made. Except to the extent required by law, Walgreens Boots Alliance does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this release, whether as a result of new information, future events, changes in assumptions or otherwise.

Notes to Editors:

About Walgreens Boots Alliance

Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led, health and wellbeing enterprise. The company's heritage of trusted health care services through community pharmacy care and pharmaceutical wholesaling dates back more than 100 years.

Walgreens Boots Alliance is the largest retail pharmacy, health and daily living destination across the U.S. and Europe. Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 25 countries and employ more than 415,000 people. The company is a global leader in pharmacy-led, health and wellbeing retail and, together with its equity method investments, has more than 18,500 stores in 11 countries as well as one of the largest global pharmaceutical wholesale and distribution networks, with more than 390 distribution centers delivering to more than 230,000 pharmacies, doctors, health centers and hospitals each year in more than 20 countries. In addition, Walgreens Boots Alliance is one of the world’s largest purchasers of prescription drugs and many other health and wellbeing products.

The company’s portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Soap & Glory, Liz Earle, Sleek MakeUP and Botanics.

Walgreens Boots Alliance is included in Fortune magazine’s 2019 list of the World’s Most Admired Companies and ranked first in the food and drugstore category. This is the 26th consecutive year that Walgreens Boots Alliance or its predecessor company, Walgreen Co., has been named to the list.

More company information is available at www.walgreensbootsalliance.com.

(WBA-GEN)


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE
04:46aWALGREENS BOOTS ALLIANCE : Declares Regular Quarterly Dividend
BU
04/17WALGREENS BOOTS ALLIANCE : Narvar and Walgreens Usher in New Era of Customer Exp..
PR
04/17To Woo Shoppers, Stores Are Accepting Competitors' Returns
DJ
04/16WALGREENS BOOTS ALLIANCE : WBA) COO Purchases 18,000 Shares of Stock
AQ
04/16Health Care, Once a Leader, Stumbles
DJ
04/10Tech in driver's seat as S&P 500 flirts with record
RE
04/10WALGREENS : and VillageMD to Offer Primary Care Services in the Houston area
BU
04/08MARKET SNAPSHOT: Stocks Close Mostly Higher As S&P 500 Pushes Wins To 8 In A ..
DJ
04/08WALGREENS BOOTS ALLIANCE : Earnings Season Could Test Bull Market in Stocks
DJ
04/08Global Stocks Pause After Last Week's Rally
DJ
More news
Financials ($)
Sales 2019 137 B
EBIT 2019 7 230 M
Net income 2019 4 526 M
Debt 2019 14 957 M
Yield 2019 3,27%
P/E ratio 2019 10,94
P/E ratio 2020 9,94
EV / Sales 2019 0,48x
EV / Sales 2020 0,45x
Capitalization 50 414 M
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 25
Average target price 60,7 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
Richard M. Ashworth President-Operations
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE-19.74%50 414
MCKESSON CORPORATION1.83%21 578
AMERISOURCEBERGEN-2.82%15 262
CARDINAL HEALTH4.82%13 375
SINOPHARM HOLDING CO LTD-2.89%12 147
SHANGHAI PHARMACEUTICALS HOLDING CO LTD24.65%8 155